As an established contract manufacturing pharmaceutical company, Ash Stevens develops, registers and manufactures Active Pharmaceutical Ingredients. We are focused on providing innovative, practical solutions to our clients in the pharmaceutical industry, whose products positively impact the patients who use them.
Ash Stevens Plots a Steady Growth Path
Ash Stevens is adding cryogenic capabilities as part of an overall strategy to focus on small molecules requiring smaller volumes and complex chemistry.
Ash Stevens Awarded Two New Contracts from NCI
Ash StevensTM was awarded two multi-year contracts from the
National Cancer Institute (NCI) totaling $12.4 million.
Ash Stevens Receives Third FDA Approval in 18 months
New cancer drug is approved to treat Pediatric Leukemias